Lucid Diagnostics is a United States medical diagnostics company focused on tests and tools for the early detection of esophageal precancer and cancer. Its products include EsoGuard, a molecular diagnostic test, and EsoCheck, a specimen collection device.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!